Paratek Pharmaceuticals, Inc.
PRTKNASDAQHealthcare
$2.23
+$0.04(+1.83%)
Market Cap$127828952
P/E Ratio—
52W High$3.65
52W Low$1.29
Paratek Pharmaceuticals, Inc. (PRTK) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRTK · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.03B | $0.10B | $0.13B | $0.22B | $0.29B |
| Net Receivables | $0.08B | $0.03B | $0.02B | $0.01B | $0.00B |
| Inventory | $0.02B | $0.01B | $0.01B | $0.01B | ($0.04B) |
| Total Current Assets | $0.14B | $0.15B | $0.16B | $0.24B | $0.26B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.17B | $0.18B | $0.18B | $0.25B | $0.30B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.04B | $0.03B | $0.02B | $0.02B | $0.02B |
| Long-Term Debt | $0.26B | $0.26B | $0.25B | $0.26B | $0.23B |
| Total Liabilities | $0.34B | $0.31B | $0.28B | $0.29B | $0.25B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.93B) | ($0.87B) | ($0.81B) | ($0.71B) | ($0.58B) |
| Total Stockholders Equity | ($0.17B) | ($0.13B) | ($0.10B) | ($0.04B) | $0.05B |
| Total Liab & Equity(computed) | $0.17B | $0.18B | $0.18B | $0.25B | $0.30B |
| Debt Summary | |||||
| Total Debt | $0.26B | $0.26B | $0.25B | $0.26B | $0.23B |
| Net Debt | $0.22B | $0.18B | $0.15B | $0.16B | ($0.06B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Paratek Pharmaceuticals, Inc. data
About Paratek Pharmaceuticals, Inc. (PRTK) Balance Sheet
Paratek Pharmaceuticals, Inc. (PRTK) balance sheet shows total assets of $0.17B with cash of $0.03B. Total liabilities are $0.34B, total debt $0.26B, and stockholders equity ($0.17B).
Frequently asked questions
PRTK · 4 questionsParatek Pharmaceuticals, Inc. has total debt of $0.26B with net debt of $0.22B.
PRTK total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10